Patent ID: 11912766
Assignee: ALLAKOS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 3:
4. The anti-Siglec-7 antibody of claim 3, wherein the variant Fc region comprises
at least one amino acid selected from the group consisting of 234A/V, 235A, 237A, 238S, 267E, 268Q, 297A/G/Q, 327G, 309L, 322Q, 328F, 330S, and 331S; or a deletion of 236; or
at least two amino acids, or at least three amino acids, selected from the group consisting of 234A/V/F, 235A/Q, 237A, 238S, 267E, 268Q, 297A/G/Q, 309L, 322Q, 327G, 328F, 330S, and 331S; and/or a deletion of 236.